Frontiers | Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
Cytolytic and degranulation marker expression on effector CD8 + T cells... | Download Scientific Diagram
Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment | Scientific Reports
Stem-like CD8+ T cells cozy up within tumors before launching an attack
Resident memory T cells, critical components in tumor immunology | Journal for ImmunoTherapy of Cancer | Full Text
Frontiers | Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
JCI Insight - CX3CR1–CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment
Screening memory T cell frequency
CD8+ T Cells | Technology Networks
NR4A and TOX Transcription Factors Mediate CD8+ T Cell Exhaustion
MEK inhibition induces stem cell memory in CD8+ T cells
Frontiers | Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors | Nature Communications
IJMS | Free Full-Text | Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion
PD-L1+CD8+ T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance - ScienceDirect
Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors - ScienceDirect
Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer - ScienceDirect
IJMS | Free Full-Text | The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Fates of CD8+ T cells in Tumor Microenvironment - ScienceDirect
CD8+ T cell metabolism in infection and cancer | Nature Reviews Immunology
CD8+ T cell differentiation and dysfunction in cancer | Nature Reviews Immunology
Activation or exhaustion of CD8+ T cells in patients with COVID-19 | Cellular & Molecular Immunology
Frontiers | CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer
